- UK firm Phytopharm and Unilever will develop a slimming aid made from a southern African cactus
- Anglo-Dutch food giant Unilever will help the pharmaceutical firm develop the snacks containing Hoodia extract
- Phytopharm will receive an initial fee of £6.5m from Unilever - out of a potential total of £21m - as well as future royalties on product sales
- Production of the Hoodia cactus at Phytopharm's nursery in South Africa will also rise from eight million plants to potentially hundreds of millions, said Phytopharm chief executive Richard Dixey
- The firm had initially hoped to market a slimming drug from Hoodia with Pfizer
